Alterations of bone mineral metabolism of children with different cell lineage types of acute lymphoblastic leukaemia under chemotherapy
- PMID: 21607035
- PMCID: PMC3093144
Alterations of bone mineral metabolism of children with different cell lineage types of acute lymphoblastic leukaemia under chemotherapy
Abstract
Background: Children with haematological malignancies such as acute lymphoblastic leukaemia (ALL) may have alteration of bone mineral metabolism therefore increased risk for osteopenia and osteoporosis.
Patients and methods: The purpose of this study was to examine the alterations of bone mineral metabolism in two groups of children (n=42) according to immunophenotyping (B-cell type, T-cell type) both quantitative (bone mineral density z-scores) and qualitative (serum osteocalcin - OC and carboxyl-terminal telopeptide of human type I collagen - ICTP) during diagnosis (T=0), after the intensified chemotherapy period (T=0.5) and the consolidation period (T=1).
Results: According to our results 15 patients had osteopenia and 1 child developed osteoporosis at T=0.5 and 13 patients had osteopenia at T=1. Mean BMD z-score was significantly decreased in both groups during chemotherapy and especially statistically significant decline of T-cell type ALL group compared with B-cell type ALL patients. OC mean level remains in low levels for both groups reaching in plateau during chemotherapy and ICTP level was increased in T-cell type ALL group of patients compared with B-cell type in both periods of chemotherapy.
Conclusions: It seems that not only the combination of chemotherapeutic agents but also the cell lineage of ALL are important parameters of altering bone mineral metabolism.
Keywords: acute lymphoblastic leukemia; bone biochemical markers; bone mineral density; cell lineage; children.
Figures
References
-
- Haddy T, Mosher R, Reaman G. Osteoporosis in survivors of acute lymphoblastic leukemia. The Oncologist. 2001;6:278–285. - PubMed
-
- Haddy TB, Adde MA, McCalla J, Domanski MJ, Datiles M, 3rd, Meehan SC, et al. Late effects in long-term survivors of highgrade non-Hodgkins lymphomas. J Clin Oncol. 1998;16:2070–2079. - PubMed
-
- Kaste SC. Skeletal toxicities of treatment in childen with cancer. Pediatr Blood Cancer. 2008;50:469–473. - PubMed
-
- Mosher RB, McCarthy BJ. Late effects in survivors of bone tumors. J Pediatr Oncol Nurs. 1998;15:72–84. - PubMed
-
- Sala A, Barr RD. Osteopenia and cancer in children and adolescents. Cancer. 2007;109:1420–1431. - PubMed
LinkOut - more resources
Full Text Sources